Clinicopathologic and molecular in situ hybridization study for HPV infection in breast cancer

于颖彦,泉启介,李亚芬
DOI: https://doi.org/10.3969/j.issn.1007-9610.2004.02.012
2004-01-01
Abstract:Objective To explore the comparative occurrence of HPV infection in breast cancer and benign breast diseases, and to observe the relationship between HPV infection and some clinicopathologic parameters. Methods A total of 116 cases of mastectomy or lumpectomy samples were collected, including 73 cases of advanced breast cancer and 43 cases of benign breast diseases. Nuclear grading (NG) of invasive ductal carcinoma, intracellular inclusion body as well as koilocytosis change were carefully observed microscopically. HPV DNA was detected by the method of in situ hybridization. Results HPV DNA was positive in 28 out of 73(39.73%) cases of breast cancer, and only 1 fibroadenoma out of 43 benign cases(2.33%) disclosed HPV infection(P0.001). HPV positive cases were mainly distributed in metaplastic carcinoma, and also in higher NG groups of invasive ductal carcinoma (P0.001). Twenty one out of 73 cases(28.77%) of breast cancer showed intracellular inclusion body, whereas 13 out of the 73 cases(17.81%)showed koilocytosis change. The positive rate for HPV detection in breast cancer cases with inclusion body and koilocytosis change was over 70% and 80%, respectively. Conclusions HPV infection exists in a proportion of breast cancer as well as in benign breast diseases. HPV positive breast cancer showed higher malignancy. Inclusion body and koilocytosis change may occur in breast cancer cells but the occurrence rate is not very high. Studies by in situ hybridization detection demonstrated: Inclusion body and koilocytosis change of breast cancer cells are closely related to HPV infection.
What problem does this paper attempt to address?